DMK
KRYS icon

David M. Knott’s Krystal Biotech KRYS Stock Holding History

David M. Knott’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-7,079
Closed -$305K – 115
2020
Q3 		$305K Hold
7,079
– – 0.18% 62
2020
Q2 		$293K Hold
7,079
– – 0.16% 58
2020
Q1 		$306K Hold
7,079
– – 0.19% 63
2019
Q4 		$392K Buy
7,079
+1,282
+22% +$62.9K 0.16% 63
2019
Q3 		$201K Hold
5,797
– – 0.08% 76
2019
Q2 		$233K Buy
5,797
+2,111
+57% +$69K 0.1% 72
2019
Q1 		$121K Buy
3,686
+2,184
+145% +$51.5K 0.05% 85
2018
Q4 		$31K Buy
+1,502
New +$31.4K 0.01% 92

Other funds holding KRYS

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

David M. Knott's KRYS Position: Q4 2020 in Review

David M. Knott sold out of Krystal Biotech (KRYS) in Q4 2020, closing a stake of 7,079 shares — an estimated $305K sold.

David M. Knott first reported a position in KRYS in Q4 2018 and held it in 8 quarters. The position peaked at $392K in Q4 2019. 108 funds tracked by Wall St. Rank hold KRYS as of Q4 2020.

  • David M. Knott reported no remaining Krystal Biotech position as of Q4 2020 after selling out during the quarter.
  • David M. Knott sold 7,079 Krystal Biotech shares in Q4 2020, an estimated $305K.
  • David M. Knott first reported a position in Krystal Biotech in Q4 2018 and held it in 8 quarters.
  • David M. Knott's Krystal Biotech position peaked at $392K in Q4 2019.
  • 108 funds tracked by Wall St. Rank held Krystal Biotech as of Q4 2020.

Based on David M. Knott's 13F filing for Q4 2020, filed 12 Feb 2021.